Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fanny Bouquet"'
Autor:
Sarah Giacometti, Bruno Lacarelle, Ariel Savina, Manon Carré, Bertrand Pourroy, Fanny Bouquet, Anne Rodallec, Guillaume Sicard, Raphaelle Fanciullino, Joseph Ciccolini
Publikováno v:
International Journal of Nanomedicine
International Journal of Nanomedicine, Dove Medical Press, 2018, 13, pp.6677-6688. ⟨10.2147/IJN.S179290⟩
International Journal of Nanomedicine, 2018, 13, pp.6677-6688. ⟨10.2147/IJN.S179290⟩
International Journal of Nanomedicine, Dove Medical Press, 2018, 13, pp.6677-6688. ⟨10.2147/IJN.S179290⟩
International Journal of Nanomedicine, 2018, 13, pp.6677-6688. ⟨10.2147/IJN.S179290⟩
Anne Rodallec,1 Guillaume Sicard,1 Sarah Giacometti,1 Manon Carré,1 Bertrand Pourroy,2 Fanny Bouquet,3 Ariel Savina,3 Bruno Lacarelle,1 Joseph Ciccolini,1 Raphaelle Fanciullino1 1SMARTc Unit, Laboratory of Pharmacokinetics and Toxicology UFR Pharmac
Autor:
Fanny Bouquet, Sarah Giacometti, Joseph Ciccolini, Bruno Lacarelle, Ariel Savina, Anne Rodallec, Jean Michel Brunel, Raphaelle Fanciullino, Helene Maccario, Florian Correard, Eric Mas, Caroline Orneto
Publikováno v:
International Journal of Nanomedicine
International Journal of Nanomedicine, Dove Medical Press, 2018, 13, pp.3451-3465. ⟨10.2147/IJN.S162454⟩
International Journal of Nanomedicine, 2018, 13, pp.3451-3465. ⟨10.2147/IJN.S162454⟩
International Journal of Nanomedicine, Dove Medical Press, 2018, 13, pp.3451-3465. ⟨10.2147/IJN.S162454⟩
International Journal of Nanomedicine, 2018, 13, pp.3451-3465. ⟨10.2147/IJN.S162454⟩
Background Trastuzumab plus docetaxel is a mainstay to treat HER2-positive breast cancers. However, developing nanoparticles could help to improve the efficacy/toxicity balance of this doublet by improving drug trafficking and delivery to tumors. Thi
Autor:
Anne Rodallec, Guillaume Sicard, Sarah Giacometti, Manon Carré, Bertrand Pourroy, Fanny Bouquet, Ariel Savina, Bruno Lacarelle, Joseph Ciccolini, Raphaelle Fanciullino
Publikováno v:
International Journal of Nanomedicine
Purpose Nanoparticles are of rising interest in cancer research, but in vitro canonical cell monolayer models are not suitable to evaluate their efficacy when prototyping candidates. Here, we developed three-dimensional (3D) spheroid models to test t